Home » Stocks » CLNN

Clene, Inc. (CLNN)

Stock Price: $6.76 USD -0.24 (-3.43%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
After-hours: $6.72 -0.04 (-0.59%) Jan 26, 4:15 PM
Market Cap 402.40M
Revenue (ttm) 177,000
Net Income (ttm) -938,670
Shares Out 59.39M
EPS (ttm) -0.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $6.76
Previous Close $7.00
Change ($) -0.24
Change (%) -3.43%
Day's Open 7.00
Day's Range 6.60 - 7.00
Day's Volume 86,868
52-Week Range 6.60 - 9.01

News

GlobeNewsWire - 3 weeks ago

Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform f...

Other stocks mentioned: TOTA

About CLNN

Clene, a clinical-stage biopharmaceutical company, focuses on the development of various therapeutics for neurodegenerative diseases. The company has a nanotechnology drug platform for the development of orally administered neurotherapeutic drugs. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative di... [Read more...]

CEO
Rob Etherington
Employees
62
Stock Exchange
NASDAQ
Ticker Symbol
CLNN
Full Company Profile